ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
批准号:
2101428
负责人:
DANIEL A ENGEL
金额:
$10.45万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1995
资助国家:
美国
项目状态:
已结题
起止时间:
1995-04-17 至 2000-03-31
关键词:
Adenoviridae HeLa cells cyclic AMP gene induction /repression genetic regulatory element genetic transcription intermolecular interaction molecular cloning neoplasm /cancer genetics nucleic acid sequence oligonucleotides plasmids protein structure function protooncogene reporter genes transcription factor viral carcinogenesis
中文摘要
对人类致癌机制的重要见解已经出现。
来自DNA肿瘤病毒的研究。DNA肿瘤病毒腺病毒
为研究转录事件提供了一个理想的系统
细胞转化。我们研究的长期目标是
了解腺病毒E1a蛋白改变细胞周期的机制
正常的细胞转录程序,从而诱导转化。
在这里,我们主要关注细胞内c-fos的转录调控。
重组腺病毒243R E1A蛋白与基因的功能相互作用
在E1a和细胞转录机制之间。我们以前的
研究发现,E1a的作用与一种重要的
细胞内信号系统,cAMP依赖的蛋白激酶途径。
这种相互作用导致一组基因的激活,这些基因是
参与细胞生长控制和转化。获得的知识
通过研究E1a对细胞转录调控的影响
WIL有助于更好地理解
转型。
1)c-fos激活中涉及的识别交易因素
在E1a和cAMP的作用下,一个22个核苷酸的“E1a-反应元件”(ERE)已经被发现
确定了243R E1a蛋白介导c-fos的激活。
ERE包含转录因子ATF/CREB的结合位点和
YY1。将确定约束该基因的因素,以及E1a的影响
而夏令营对其水平和活动的影响将被确定。
2)ATF/CREB-YY1复合体的结构和功能。YY1实体
与转录因子AFT/CREB家族成员相互作用。
作为研究ATF/CREB-YY1复合体在
ATF/CREB-YY1的活化b E1a、结构/功能分析
将进行互动。DNA结合和转录
还将调查该建筑群的镇压。
3)作为E1a靶点的ATF/CREB-YY1复合体。E1a可与YY1结合,
改变其DNA结合特性。E1a和YY1的相互作用,
并研究了E1a与ATF/CREB-YY1络合物之间的相互作用。实验
将包括对E1A-YY1相互作用的结构/功能分析,如
以及体外和体内结合试验。这些实验将导致
建立了c-fos基因E1a激活的分子基础模型。
英文摘要
Important insights into the mechanisms of human carcinogenesis have come
from the study of DNA tumor viruses. The DNA tumor virus adenovirus
provides an ideal system for investigating transcriptional events in
cellular transformation. The long-term goal of our research is to
understnd the mechanism by which the adenovirus E1A protein alters the
normal cellular transcriptional program so as to induce transformation.
Here, we focus on the transcriptional regulation of the cellular c-fos
gene by the adenovirus 243R E1A protein, and the functional interaction
between E1A and the cellular transcriptional machinery. Our previous
studies have identified a link between the action of E1A and an important
intracellular signling system, the cAMP-dependent protein kinase pathway.
This interaction results in the activation of a set of genes that are
involved in cellular growth control and transformation. Knowledge gained
from studying the effects ofE1A on cellular transcriptional regulation
wil lead to better understanding of the molecular events involved in
transformation.
1) Identifiction transacting factors involved in the activation of c-fos
by E1A and cAMP, A 22 nucleotide "E1A-response element" (ERE) has been
identified that mediates activation of c-fos by the 243R E1A protein.
The ERE contains binding sites for transcription factors ATF/CREB and
YY1. Factors tht bind the ERE will be identified, and the effects of E1A
and cAMP on their level and activity will be determined.
2) Structure and function of the ATF/CREB-YY1 complex. YY1 physically
interacts with members of the AFT/CREB family of transcription factors.
As a prelude to investigating the role of the ATF/CREB-YY1 complex in
activation b E1A, structure/function analysis of the ATF/CREB-YY1
interaction will be performed. DNA-binding and transcriptional
repression by the complex will also be investigated.
3) The ATF/CREB-YY1 complex as a target ofE1A. E1A can bind to YY1 and
alter its DNA-binding properties. The interaction between E1A and YY1,
and between E1A and the ATF/CREB-YY1 complex will e studied. Experiments
will include structure/function analysis of the E1A-YY1 interaction, as
well as in itro and in vivo binding assays. These experiments will lead
to a model for the molecular basis of E1a activation of thec-fos gene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small molecule inhibitors of influenza virus nucleoprotein
-
批准号:10255568
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8277243
-
项目类别:
-
资助金额:$83.53万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8466918
-
项目类别:
-
资助金额:$76.44万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8661106
-
项目类别:
-
资助金额:$82.68万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:8076338
-
项目类别:
-
资助金额:$84.44万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Discovery and development of broad spectrum anti-flaviviral drugs
-
批准号:7939155
-
项目类别:
-
资助金额:$86.91万
-
财政年份:2010
-
负责人:DANIEL A ENGEL
-
依托单位:
Development of Yeast-Based Assays for anti-influenza drug discovery
-
批准号:7153162
-
项目类别:
-
资助金额:$66.56万
-
财政年份:2006
-
负责人:DANIEL A ENGEL
-
依托单位:
Novel Tool Compounds for Chromatin Research
-
批准号:6735954
-
项目类别:
-
资助金额:$20.76万
-
财政年份:2004
-
负责人:DANIEL A ENGEL
-
依托单位:
CHROMATIN TARGETS FOR CANCER THERAPY
-
批准号:6189356
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2000
-
负责人:DANIEL A ENGEL
-
依托单位:
CHROMATIN TARGETS FOR CANCER THERAPY
-
批准号:6378054
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2000
-
负责人:DANIEL A ENGEL
-
依托单位:
CHROMATIN TARGETS FOR CANCER THERAPY
-
批准号:6514674
-
项目类别:
-
资助金额:$26.64万
-
财政年份:2000
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2895049
-
项目类别:
-
资助金额:$10.32万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6287364
-
项目类别:
-
资助金额:$22.52万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6624724
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2390788
-
项目类别:
-
资助金额:$10.31万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6685930
-
项目类别:
-
资助金额:$23.1万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6475895
-
项目类别:
-
资助金额:$23.11万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS E1A PROTEIN AND THE SWI/SNF COMPLEX
-
批准号:6836524
-
项目类别:
-
资助金额:$23.1万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2101429
-
项目类别:
-
资助金额:$10.34万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
ADENOVIRUS 243R E1A PROTEIN AND CELLULAR TRANSCRIPTION
-
批准号:2683544
-
项目类别:
-
资助金额:$10.32万
-
财政年份:1995
-
负责人:DANIEL A ENGEL
-
依托单位:
海外基金